Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Yellowhammer heightens supply fears
The majority of vet medicines used in the UK are either produced, or enter via, the EU.
NOAH and BVA express ‘no-deal’ concerns

According to a statement released by NOAH on 12 September in response to the Government’s publication of its Operation Yellowhammer document, the majority of veterinary medicines used in the UK – including the ingredients and components needed to make them – are either produced in, or enter via, the EU.
 
NOAH states: ’Our industry has been working closely with regulators, and has responded very well to concerns about supply, with detailed planning measures for all EU Exit scenarios, including no deal. These plans have involved a great deal of work and cover all aspects of supply chains from regulatory compliance and stocking levels to logistics and customs.

‘They also include, as appropriate, increasing stocks of products in the UK, changing supply routes, transferring marketing authorisations and other regulatory processes. However, in a no-deal situation there are also broader issues that could impact on availability of veterinary medicines.’

An example of this is the supply of ‘temperature-sensitive’ vaccines that have to be maintained in certain conditions. If transport is delayed and they are stuck on a lorry for hours with no power supply, those vaccines could become completely useless, and the consignment lost.

Commenting on the Government paper, Dawn Howard, NOAH chief executive, pointed out that any disruption in supplies will represent a potential risk to controlling disease and is an animal welfare issue. If preventive medicines, such as vaccines, are not available, there is a greater risk of disease in the population, including the spread of zoonotic infections.

Endorsing this position, BVA president, Simon Doherty, said: “Continued access to veterinary medicines post-Brexit is essential for safeguarding animal health and welfare, public safety and the food chain in the UK. Our concerns with regards to veterinary medicines lie with those for long-term health conditions and medicines that have a short shelf life, such as vaccines.
 
“While we don’t advise the stockpiling of medicines, we would advise animal owners to discuss the timing of any vaccinations with their vet. We would also urge pet owners whose animals are undergoing long-term treatment to seek repeat prescriptions in good time from their veterinary practice.”
 

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
APHA launches free virtual work experience programme

The Animal and Plant Health Agency (APHA), in collaboration with Springpod, has launched a free virtual work experience programme, giving young people across the UK the chance to explore careers dedicated to protecting animal and plant health.

The on-demand programme offers a unique insight into career opportunities within APHA, showcasing how students can contribute to tackling some of the UK's most critical biosecurity and environmental challenges.

Designed for students aged 13 and over, the course includes more than 10 hours of engaging content featuring real-life industry insights, scenario-based challenges, and practical guidance on applying for jobs. To register for the course, visit the APHA website.